Cellistic Introduces Echo™-NK Platform to Power Scalable Off-the-Shelf NK Cell Therapies for Cancer and Autoimmune Diseases

Cellistic, a pioneer in induced pluripotent stem cells (iPSC)-based cell therapies, is launching the Echo™-NK platform to enable the scalable manuf...

April 11, 2025 | Friday | News
China, India, and Africa at the Forefront as Type 5 Diabetes Gains Global Recognition

Malnutrition-related diabetes—typically affecting lean, malnourished teens and young adults in low- and middle-income countries—is now offici...

April 09, 2025 | Wednesday | Reports
South Korea Makes History with World’s First Recombinant Anthrax Vaccine Approval

GC Biopharma announced 09. Apr. 2025 that the Korean Ministry of Food and Drug Safety (MFDS) has approved its anthrax vaccine, BARYTHRAX, jointly develop...

April 09, 2025 | Wednesday | News
Innocan Pharma Advances Global Patent Strategy with Divisional Application for Liposome-Based CBD Technology in China

 Innocan Pharma Corporation, a pioneer in the pharmaceutical and biotechnology industries, is pleased to announce that a divisional application for it...

April 08, 2025 | Tuesday | News
BIO CEO John F. Crowley Warns of Lasting Damage if Pharma Tariffs Move Forward

  Will Tariffs Hit Pharmaceuticals? The Calm Before the Storm While the pharmaceutical industry may have narrowly escaped the latest wave of U.S. ta...

April 08, 2025 | Tuesday | News
Rhythm Pharmaceuticals to Announce Topline Results from Phase 3 TRANSCEND Trial of Setmelanotide in Acquired Hypothalamic Obesity

Rhythm Pharmaceuticals, Inc., a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendoc...

April 07, 2025 | Monday | News
NetraMark and Worldwide Clinical Trials Partner to Advance AI-Driven Precision in Global Clinical Trials

NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company th...

April 04, 2025 | Friday | News
Cytiva Expands MabSelect Resin Portfolio to Advance Affordable and Scalable mAb Purification

  MabSelect SuRe 70 and MabSelect PrismA X resins to set new standards in affordability and productivity Cytiva's expanded resin portfolio will ...

April 03, 2025 | Thursday | News
DuPont Launches Liveo™ Pharma TPE Ultra-Low Temp Tubing for Demanding Biopharma Processing Needs

  Sterilizable, weldable, sealable thermoplastic elastomer tubing intended for biopharmaceutical processing applications that require low temperature...

April 03, 2025 | Thursday | News
Lonza Launches New Operating Model to Power ‘One Lonza’ Vision and Streamline CDMO Business

Lonza’s new simplified and streamlined operating model is designed to support its One Lonza vision and strategy Previous divisional structure ...

April 02, 2025 | Wednesday | News
India’s Gennova Biopharmaceuticals Partners with CEPI to Advance AI-Enhanced Self-Amplifying mRNA Vaccines

Gennova Biopharmaceuticals Ltd., a pioneering company in mRNA technology and vaccine development, is proud to announce a strategic partnership with the C...

April 01, 2025 | Tuesday | News
Regeneron and Sanofi Receive Approval for Dupixent® in Japan to Treat Chronic Obstructive Pulmonary Disease (COPD)

TARRYTOWN -- Regeneron Pharmaceuticals, and Sanofi announced that the Ministry of Health, Labour and Welfare (MHLW) in Japan ...

March 31, 2025 | Monday | News
AstraZeneca’s Calquence® Combination Therapy Recommended for EU Approval in Untreated Mantle Cell Lymphoma

AstraZeneca’s Calquence (acalabrutinib) in combination with bendamustine and rituximab has been recommended for approval in the European Un...

March 31, 2025 | Monday | News
Sanofi’s mRNA Chlamydia Vaccine Candidate Receives Fast Track Designation from FDA

The US Food and Drug Administration has granted fast track designation to Sanofi’s mRNA vaccine candidate for the prevention of chlamydia infection. ...

March 28, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close